Chemokine receptor antagonists as therapeutic agents

作者: Stephen C. Peiper , David H. Munn , Andrew L. Mellor

DOI:

关键词:

摘要: The present invention provides methods and compositions to reduce immune tolerance at specific sites. In one aspect, the comprises tumorigenicity. an embodiment, reduces recruitment of tolerance-inducing antigen presenting cells (APCs) or their precursors a tumor and/or draining lymph node by decreasing binding least tumor-associated ligand chemokine receptor on APCs APC precursors. is CCR6 mip-3α. another virus. virus HIV. further for development antibodies antagonists as therapeutic agents prevent tolerance.

参考文章(111)
Albert Zlotnik, Osamu Yoshie, Chemokines: A New Classification System and Their Role in Immunity Immunity. ,vol. 12, pp. 121- 127 ,(2000) , 10.1016/S1074-7613(00)80165-X
Andrew L. Mellor, Jayabalan Sivakumar, Phillip Chandler, Kimberly Smith, Hector Molina, Dailing Mao, David H. Munn, Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nature Immunology. ,vol. 2, pp. 64- 68 ,(2001) , 10.1038/83183
P Szabolcs, D Avigan, S Gezelter, DH Ciocon, MA Moore, RM Steinman, JW Young, Dendritic Cells and Macrophages Can Mature Independently From a Human Bone Marrow - Derived, Post - Colony-Forming Unit Intermediate Blood. ,vol. 87, pp. 4520- 4530 ,(1996) , 10.1182/BLOOD.V87.11.4520.BLOODJOURNAL87114520
Sally R. M. Bennett, Francis R. Carbone, Freda Karamalis, Richard A. Flavell, Jacques F. A. P. Miller, William R. Heath, Help for cytotoxic-T-cell responses is mediated by CD40 signalling Nature. ,vol. 393, pp. 478- 480 ,(1998) , 10.1038/30996
Ken Shortman, William R. Heath, Immunity or tolerance? That is the question for dendritic cells. Nature Immunology. ,vol. 2, pp. 988- 989 ,(2001) , 10.1038/NI1101-988